Characterization of a pyrazolo[4,3-d]pyrimidine inhibitor of cyclin-dependent kinases 2 and 5 and Aurora A with pro-apoptotic and anti-angiogenic activity in vitro.
Journal article published in 2015 by
Karel Berka 
